• All Products
  • By Generic
  • By Therapeutic Segment


Therapeutic Segment: Anti-Coagulant

Generic Name: Rivaroxaban


For the treatment of the following conditions:

  • Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Reduction in the risk of recurrence of deep vein thrombosis and of pulmonary embolism following initial 6 months’ treatment for DVT and/or PE.
  • Prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery.

Available as:

  • 10MG
  • 15MG
  • 20MG